Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

HEPA

$0.07+31.58%

Hepion Pharmaceuticals, Inc.

Market Cap
$8M
Sector
Materials
Industry
Pharmaceuticals
Beta
1.82
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
25.6x
buying
Congress
—
recent trades
Short Volume
—
of daily vol

Market & Alt Data

News
2
recent articles
Activist
13D
Hepion
Analyst Consensus
Strong Buy
7 analysts
Velocity Score
25.65x
Current Rate (90d)
116666.67/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
3
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-08-032026-08-12Appajosyula SireeshDirector & Chief Operating OfficerPurchase2.00M$0.05$100K3.25MView
2026-08-032026-08-12Stetz Gary S. IIDirectorPurchase500.0K$0.05$25K500.0KView
2026-08-032026-08-12LoPriore Vincent SDirector & Executive ChairmanPurchase8.00M$0.05$400K14.25MView
2026-04-212026-04-27Purcell Michael J.DirectorPurchase1.25M$0.04$50K1.25MView
2026-04-212026-04-27LoPriore Vincent SDirector & Executive ChairmanPurchase5.00M$0.04$200K5.00MView

Recent News

Northrop Grumman Corporation (NOC)’s XRQ-73 SHEPARD Uncrewed Aircraft Begins Flight Testing
Yahoo Finance · 2026-05-13
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma
Yahoo Finance · 2026-03-03

Informational purposes only, not investment advice.

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →